Is pT2 subclassification feasible to predict patient outcome in colorectal cancer?

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1389-1396

  Tong, Lin Lin ^a   Gao, Peng ^a   Wang, Zhen Ning ^a   Yue, Zhen Yu ^a   Song, Yong Xi ^a   Sun, Zhe ^a   Lu, Yi ^a   Xing, Cheng Zhong ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE HEMATOGENOUS METASTASIS; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 79955833895     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1440-2     Document Type: Article

References (23)

1. Schottenfeld D, Winawer SJ. Cancers of the large intestine. In: Schottenfeld D, Fraumeni JF, eitors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996.
2. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics, 1999 CA Cancer J Clin. 49 8 31 10200775 10.3322/canjclin.49.1.8 1:STN:280: DyaK1M3hs1OrsA%3D%3D (Pubitemid 29094959)
3. J Peto 2001 Cancer epidemiology in the last century and the next decade Nature. 411 390 395 11357148 10.1038/35077256 1:CAS:528:DC%2BD3MXktVSjs7s%3D (Pubitemid 32467050)
4. H Tsukuma W Ajiki 2003 Descriptive epidemiology of colorectal cancer-international comparison Nippon Rinsho 61 Suppl 7 25 30 14574850
5. B Levin D Brooks RA Smith A Stone 2003 Emerging technologies in screening for colorectal cancer: CT colonography immunochemical fecal occult blood tests, and stool screening using molecular markers CA Cancer J Clin. 53 44 55 12568443 10.3322/canjclin.53.1.44 (Pubitemid 36163621)
6. A Jemal R Siegel E Ward Y Hao J Xu T Murray, et al. 2008 Cancer Statistics, 2008 CA Cancer J Clin. 58 71 96 18287387 10.3322/CA.2007.0010 (Pubitemid 351521864)
7. AG Xu B Jiang XH Zhong JH Liu 2006 Clinical epidemiological characteristics of 3870 cases of colorectal cancers in Guangdong region Zhonghua Nei Ke Za Zhi. 45 9 12 16624079
8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
9. K Kitamura S Nishida K Yamamoto D Ichikawa K Okamoto K Sawai, et al. 1998 Mp colorectal cancer should be defined as early colorectal cancer Tohoku J Exp Med. 184 285 293 9699244 10.1620/tjem.184.285 1:STN:280:DyaK1czmsVCjsg%3D%3D (Pubitemid 128472958)
10. KS Chok WL Law 2007 Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer World J Surg. 31 1485 1490 17510767 10.1007/s00268-007-9089-0 (Pubitemid 46945379)
11. L Losi G Ponti CD Gregorio M Marino G Rossi M Pedroni, et al. 2006 Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma Pathol Res Pract. 202 663 670 16860493 10.1016/j.prp.2006.05.003
12. MJ Pollheimer P Kornprat VS Pollheimer RA Lindtner A Schlemmer P Rehak, et al. 2010 Clinical significance of pT sub-classification in surgical pathology of colorectal cancer Int J Colorectal Dis. 25 187 196 19816699 10.1007/s00384-009-0801-4
13. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss Inc.; 1997.
14. KJ Boudreaux Jr PE Clark WT Lowrance JA Rumohr DA Barocas MS Cookson, et al. 2009 Comparison of American Joint Committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer J Urol. 181 540 545 19084855 10.1016/j.juro.2008.10.038 discussion 546
15. RJ Yu JP Stein J Cai G Miranda S Groshen DG Skinner 2006 Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy J Urol. 176 493 498 16813876 10.1016/j.juro.2006. 03.065 discussion 498-9 (Pubitemid 43927925)
16. Z Sun GL Zhu C Lu PT Guo BJ Huang K Li, et al. 2009 A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa Ann Surg. 249 768 775 19387327 10.1097/SLA.0b013e3181a3df77
17. R Ricciardi RD Madoff DA Rothenberger NN Baxter 2006 Population-based analyses of lymph node metastases in colorectal cancer Clin Gastroenterol Hepatol. 4 1522 1527 16979956 10.1016/j.cgh.2006.07.016 (Pubitemid 44880022)
18. WL Fang SC Chang JK Lin HS Wang SH Yang JK Jiang, et al. 2005 Metastatic potential in T1 and T2 colorectal cancer Hepatogastroenterology. 52 1688 1691 16334758
19. T Masaki H Matsuoka M Sugiyama N Abe A Sakamoto T Watanabe, et al. 2005 Tumor budding and evidence-based treatment of T2 rectal carcinomas J Surg Oncol. 92 59 63 16180229 10.1002/jso.20369 (Pubitemid 41417778)
20. PJ Sitzler F Seow-Choen YH Ho AP Leong 1997 Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients Dis Colon Rectum. 40 1472 1476 9407987 10.1007/BF02070714 1:STN:280:DyaK1c%2FmvFyktA%3D%3D (Pubitemid 27528287)
21. DK Sohn HJ Chang JW Park DH Choi KS Han CW Hong, et al. 2007 Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type J Clin Pathol. 60 912 915 16997919 10.1136/jcp.2006.043539 (Pubitemid 47234439)
22. S Yamamoto M Watanabe H Hasegawa H Baba K Yoshinare J Shiraishi, et al. 2004 The risk of lymph node metastasis in T1 colorectal carcinoma Hepatogastroenterology. 51 998 1000 15239233 (Pubitemid 38822457)
23. K Tominaga Y Nakanishi S Nimura K Yoshimura Y Sakai T Shimoda 2005 Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma Dis Colon Rectum. 48 92 100 15690664 10.1007/s10350-004-0751-4 (Pubitemid 40895660)